Senior Vice President of SFL, Veristat company, Shayesteh Fürst-Ladani, in her role as President of the Rare Disease Action Forum (RDAF), will take part in the panel on orphan drug pricing during the ITINERARE Symposium organized by the University of Zurich ITINERARE on 1 December 2022. Together with the panelists she will discuss challenges to improve patient’s access to orphan drugs, explore potential solutions and sharing perspectives on the current challenges and potential solutions to streamline and simplify the process for orphan drug price setting.